arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CYPHERPUNK TECHNOLOGIES INC.

CYPH
$2.46 ▼ -0.42 (-14.41%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Neutral
auto_awesome

Analytical Summary

CYPHERPUNK TECHNOLOGIES INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $162.7M
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -12.8% ↗
FCF / Share $-0.66 ↗
Trailing P/E 35.1x
Price / Book 1.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.50M
— 0.0% —
Net Income Profit after all expenses
$4.82M
↑ +107.1% —
FCF / Share Free cash flow per share
$-0.66
↑ +58.7% —

Health Breakdown

Returns
50
Cash Quality
2

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 43 quarters